Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $3.40 in the prior trading day, Revelation Biosciences Inc (NASDAQ: REVB) closed at $3.00, down -11.76%. In other words, the price has decreased by -$11.76 from its previous closing price. On the day, 2.25 million shares were traded. REVB stock price reached its highest trading level at $3.03 during the session, while it also had its lowest trading level at $2.3601.
Ratios:
Our goal is to gain a better understanding of REVB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.43 and its Current Ratio is at 3.43. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, REVB now has a Market Capitalization of 2715684 and an Enterprise Value of -3783334.
Stock Price History:
The Beta on a monthly basis for REVB is 0.10, which has changed by -0.9177632 over the last 52 weeks, in comparison to a change of 0.09589827 over the same period for the S&P500. Over the past 52 weeks, REVB has reached a high of $60.80, while it has fallen to a 52-week low of $3.19. The 50-Day Moving Average of the stock is -40.24%, while the 200-Day Moving Average is calculated to be -79.90%.
Shares Statistics:
The stock has traded on average 219.42K shares per day over the past 3-months and 261150 shares per day over the last 10 days, according to various share statistics. A total of 0.91M shares are outstanding, with a floating share count of 0.90M. Insiders hold about 0.03% of the company’s shares, while institutions hold 3.93% stake in the company. Shares short for REVB as of 1740700800 were 61699 with a Short Ratio of 0.28, compared to 1738281600 on 63430. Therefore, it implies a Short% of Shares Outstanding of 61699 and a Short% of Float of 11.82.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
At present, 2.0 analysts are actively evaluating the performance of Revelation Biosciences Inc (REVB) in the stock market.The consensus estimate for the next quarter is -$5.97, with high estimates of -$1.93 and low estimates of -$10.0.
Analysts are recommending an EPS of between -$4.51 and -$38.9 for the fiscal current year, implying an average EPS of -$21.7. EPS for the following year is -$2.9, with 1.0 analysts recommending between -$2.9 and -$2.9.
